Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synbiotics Limited is an Indian pharmaceutical company and a subsidiary of Ambalal Sarabhai Enterprises, specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) through fermentation and chemical synthesis. The company is notably one of the few global producers of Streptomycin Sulfate and Amphotericin B, which are critical for treating tuberculosis and systemic fungal infections, respectively. Operating out of Vadodara, Gujarat, Synbiotics provides high-quality bulk drugs to both domestic and international markets, maintaining a strong focus on fermentation-based biotechnology. Its facilities are designed to meet global regulatory standards, supporting its role as a key supplier in the anti-infective therapeutic segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synbiotics.